132 related articles for article (PubMed ID: 30980862)
1. Angiotensin II type I receptor antibodies in thoracic transplantation.
Zhang X; Reinsmoen NL
Hum Immunol; 2019 Aug; 80(8):579-582. PubMed ID: 30980862
[TBL] [Abstract][Full Text] [Related]
2. The impact of angiotensin II type 1 receptor antibodies on post-heart transplantation outcome in Heart Mate II bridged recipients.
Urban M; Slavcev A; Gazdic T; Ivak P; Besik J; Netuka I
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):292-7. PubMed ID: 26675563
[TBL] [Abstract][Full Text] [Related]
3. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
[TBL] [Abstract][Full Text] [Related]
4. Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies.
Lim MA; Palmer M; Trofe-Clark J; Bloom RD; Jackson A; Philogene MC; Kamoun M
Hum Immunol; 2017 Apr; 78(4):350-356. PubMed ID: 28284829
[TBL] [Abstract][Full Text] [Related]
5. The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients.
Marian U; Slavcev A; Gazdic T; Ivak P; Netuka I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):518-523. PubMed ID: 27132810
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II Type 1 Receptor Expression in Renal Transplant Biopsies and Anti-AT1R Antibodies in Serum Indicates the Risk of Transplant Loss.
Sas-Strózik A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Gawlik K; Mazanowska O; Madziarska K; Hałoń A; Krajewska M; Banasik M
Transplant Proc; 2020 Oct; 52(8):2299-2304. PubMed ID: 32448653
[TBL] [Abstract][Full Text] [Related]
7. The detection of antibodies to the Angiotensin II-type 1 receptor in transplantation.
Dragun D
Methods Mol Biol; 2013; 1034():331-3. PubMed ID: 23775747
[TBL] [Abstract][Full Text] [Related]
8. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Reinsmoen NL; Mirocha J; Ensor CR; Marrari M; Chaux G; Levine DJ; Zhang X; Zeevi A
Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
[TBL] [Abstract][Full Text] [Related]
9. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
Malheiro J; Tafulo S; Dias L; Martins S; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Nephrology (Carlton); 2019 Mar; 24(3):347-356. PubMed ID: 29451342
[TBL] [Abstract][Full Text] [Related]
10. The early impact of preformed angiotensin II type 1 receptor antibodies on graft function in a low immunological risk cohort of kidney transplant recipients.
Sorohan BM; Ismail G; Berechet A; Obrișcă B; Constantinescu I; Mărunțelu I; Tacu D; Baston C; Sinescu I
Transpl Immunol; 2021 Jun; 66():101389. PubMed ID: 33838295
[TBL] [Abstract][Full Text] [Related]
11. Successful Treatment of Anti-angiotensin II Type 1 Receptor Antibody-Associated Rejection in Kidney Transplantation: A Case Report.
Wiwattanathum P; Ingsathit A; Thammanichanond D; Worawichawong S
Transplant Proc; 2018 Apr; 50(3):877-880. PubMed ID: 29331505
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
Min JW; Lee H; Choi BS; Park CW; Yang CW; Kim YS; Choi YJ; Oh EJ; Chung BH
Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
[TBL] [Abstract][Full Text] [Related]
13. Rejection and graft outcomes in kidney transplant recipients with and without angiotensin II receptor type 1 antibodies.
Aljishi M; Isbel NM; Jegatheesan D; Johnson DW; Cho Y; Campbell SB; Hawley CM; Thornton A; Gillis D; Johnstone K
Transpl Immunol; 2023 Feb; 76():101756. PubMed ID: 36460263
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney transplant rejection mediated by angiotensin II type 1 receptor antibodies in a pediatric hyperimmune patient.
Guzzo I; Morolli F; Camassei FD; Piazza A; Poggi E; Dello Strologo L
Pediatr Nephrol; 2017 Jan; 32(1):185-188. PubMed ID: 27752765
[TBL] [Abstract][Full Text] [Related]
15. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested?
Philogene MC; Zhou S; Lonze BE; Bagnasco S; Alasfar S; Montgomery RA; Kraus E; Jackson AM; Leffell MS; Zachary AA
Hum Immunol; 2018 Apr; 79(4):195-202. PubMed ID: 29428484
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.
Philogene MC; Johnson T; Vaught AJ; Zakaria S; Fedarko N
Hum Immunol; 2019 Aug; 80(8):561-567. PubMed ID: 31010696
[TBL] [Abstract][Full Text] [Related]
17. Revealing a new mode of sensitization induced by mechanical circulatory support devices: Impact of anti-AT
Zhang X; Mirocha J; Aintablian T; Dimbil S; Moriguchi J; Arabia F; Kobashigawa JA; Reinsmoen N
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29245181
[TBL] [Abstract][Full Text] [Related]
18. Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Deltombe C; Gillaizeau F; Anglicheau D; Morelon E; Trébern-Launay K; Le Borgne F; Rimbert M; Guérif P; Malard-Castagnet S; Foucher Y; Giral M
Transpl Int; 2017 Nov; 30(11):1150-1160. PubMed ID: 28686316
[TBL] [Abstract][Full Text] [Related]
19. Preformed Angiotensin II Type-1 Receptor Antibodies Are Associated With Rejection After Kidney Transplantation: A Single-Center, Cohort Study.
Kim D; Gimferrer I; Warner P; Nelson K; Sibulesky L; Bakthavatsalam R; Leca N
Transplant Proc; 2018 Dec; 50(10):3467-3472. PubMed ID: 30577222
[TBL] [Abstract][Full Text] [Related]
20. Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.
Pearl MH; Leuchter RK; Reed EF; Zhang Q; Ettenger RB; Tsai EW
Pediatr Nephrol; 2015 Aug; 30(8):1371-4. PubMed ID: 25956702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
